Arelis

Reimagining women's health with advanced, non-invasive screening for endometriosis.

Arelis is reimagining diagnostics in women’s health - starting with endometriosis.

Our non-invasive urine test uses infrared spectroscopy and AI to deliver fast, accurate risk results, cutting diagnostic delays from years to weeks. Built for clinical impact, accessibility, and scale, Arelis gives providers a powerful new tool to diagnose sooner and treat faster. We're closing a critical gap in care and setting a new standard for how underdiagnosed conditions are identified and managed.

Achievements:

1. Advanced discussions underway with AERI at UNSW to initiate a clinical trial; protocol planning in progress. 2 - Regulatory pathway clarified through expert guidance from the UNSW Accelerator program. 3 - Secured commitment for a real-world evaluation in New Zealand in collaboration with key opinion leaders and industry partners.

Team: Tori Fox - Founder and CEO; Chris Dunn - Founder and Operations Director; Prof. Maneesh Singh - Founder and CMO; Prof. Frank Martin - Founder and CSO.

Tori Fox - Founder and CEO